Jie Wang

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Tony Mok, Yi‐Long Wu, Iveta Kudaba et al. · The Lancet · 2019 · 3.3K citations · Full text

Medicine, Oncology, Pharmacology +15

A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse

Jie Wang, Toshiyuki Takeuchi, Shigeyasu Tanaka et al. · Journal of Clinical Investigation · 1999 · 570 citations · Full text

Medicine, Endocrinology, Molecular Biology +17

Dominant Negative Pathogenesis by Mutant Proinsulin in the Akita Diabetic Mouse

Tetsuro Izumi, Hiromi Yokota‐Hashimoto, Shengli Zhao et al. · Diabetes · 2003 · 217 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +17

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses

Tony Mok, Sang‐We Kim, Yi‐Long Wu et al. · Journal of Clinical Oncology · 2017 · 187 citations

Medicine, Oncology, Pharmacology +17

Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia

Li‐Sheng Wang, Jie Wang, Bradley W. Blaser et al. · Blood · 2007 · 133 citations · Full text

Medicine, Oncology, Pharmacology +17